Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma

Published:2021-03-05 Issue:7 Volume:17 Page:1882-1896
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Xu Yuexin¹^ORCID,Miller Chris P.¹,Warren Edus H.¹²³^ORCID,Tykodi Scott S.¹³^ORCID

Affiliation:

1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

2. Department of Pathology, University of Washington School of Medicine, Seattle, WA, USA

3. Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA

Funder

Cancer Research Institute

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1870846

Reference156 articles.

1. Cancer statistics, 2019

2. Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

3. SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA

4. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

5. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding and Therapeutic Application of Immune Response in Major Histocompatibility Complex (MHC) Diversity Using Multimodal Artificial Intelligence;BioMedInformatics;2024-08-05

2. Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma;Cells;2023-12-22

3. The Changing Landscape of Immunotherapy for Advanced Renal Cancer;Urologic Clinics of North America;2023-05

4. Understanding the Tumor Immune Microenvironment in Renal Cell Carcinoma;Cancers;2023-04-27

5. Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy;Frontiers in Immunology;2023-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3